Evaluation of pyridine-3-carboxylic acid as a drug carrier by utilizing multivariate methods, structure property correlations, and pattern recognition techniques

Receptors and Channels

Volumn 10, Issue 2, 2004, Pages 61-71

  Bartzatt, Ronald L ^a  

^a UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

Author keywords

Dihydropyridine; Nicotinic acid; Pattern recognition

Indexed keywords

4 AMINO 5 HEXYNOIC ACID; ANTICONVULSIVE AGENT; BARBITAL; DIHYDROPYRIDINE; DRUG CARRIER; METHARBITAL; METHOHEXITAL; NICOTINIC ACID; PHENOBARBITAL;

ALGORITHM; ARTICLE; CENTRAL NERVOUS SYSTEM; CHEMICAL STRUCTURE; CLUSTER ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG STRUCTURE; EVALUATION; FACTORIAL ANALYSIS; LINKAGE ANALYSIS; MATHEMATICAL COMPUTING; MULTIPLE REGRESSION; MULTIVARIATE ANALYSIS; PATTERN RECOGNITION; PREDICTION; PRIORITY JOURNAL; STRUCTURE ANALYSIS;

ALGORITHMS; ANIMALS; BIOLOGICAL AVAILABILITY; BLOOD-BRAIN BARRIER; DRUG CARRIERS; DRUG EVALUATION, PRECLINICAL; HUMANS; MODELS, CHEMICAL; MOLECULAR STRUCTURE; MULTIVARIATE ANALYSIS; NIACIN; PATTERN RECOGNITION, AUTOMATED; SOFTWARE;

EID: 3543074530     PISSN: 10606823     EISSN: None     Source Type: Journal    
DOI: 10.1080/10606820490464325     Document Type: Article

References (30)

1. Anderberg, M. R. 1973. Cluster analysis for applications. New York. Academic Press, pp. 50-75.
2. Bartzatt, R. 2004. Drug Delivery 11(1): 19-26.
3. Bartzatt, R., and Donigan, L. 2003. Receptors and Channels 9:309-313.
4. Bodor, N. 1999. Pharma Sciences 7(1):43-52.
5. Brewster, M., and Bodor, N. 1983. Journal of Parenteral Science and Technology 37(5):159-164.
6. Clark, D. 1999. Journal of Pharmaceutical Sciences 88(8):815-821.
7. Ertl, P., Rohde, B., and Selzer, P. 2000. J. Med. Chem. 43:3714-3717.
8. Gong, X., and Richman, M. B. 1995. J. Climate 8:897-931.
9. Goodman, L., and Gilman, A. 1970. The pharmacological basis of therapeutics. New York. Macmillan Corp, pp. 25-100.
10. Hansch, C., and Leo, A. 1995. Exploring QSAR. Washington D.C. ACS Professional Reference Book.
11. Herrero, J., Valencia, A., and Dopazo, J. (2001). Bioinformatics 17:126-136.
12. Kelder, J., Grootenhuis, P. D. J., Bayada, D., Delbressine, L. P. C., and Ploemen, J. 1999. Pharmaceutical Research 16(10):1514-1519.
13. Linpinski, C. A., Lombardo, F., Dominy, B. W., and Feeney P. J. 1997. Adv. Drug Delivery Rev. 23:4-25.
14. Lipinski, C. A. 2000. Journal of Pharmacological and Toxicological Methods 44:235-249.
15. Molema, G., and Meijer D. 2001a. Drug targeting, pp. 23-35. New York: Wiley-VCH.
16. Molema, G., and Meijer D. 2001b. Drug targeting p. 35. New York (Wiley-VCH).
17. Moriguchi, I., Hirono, S., Liu, Q., Nakagome, I., and Matsushita, Y. 1992. Chem. Phar. Bull. 40(1):127-130.
18. Palma, K., Luthman, K., Ungell, A., Strandlund, G., and Artursson, P. 1996. Journal of Pharmaceutical Sciences 85(1):32-39.
19. Palm, K., Stenberg, P., Luthman, K., and Artursson, P. 1997. Pharmaceutical Research 14(5):568-571.
20. Pop, E., Whei-Mei, W., and Nicholas, B. 1989a. J. Med. Chem. 32:1789-1795.
21. Pop, E., Whei-Mei, W., Shek, E., and Bodor N. 1989b. J. Med. Chem. 32:1774-1781.
22. Saunders, N. R., Habgood, M. D., and Dziegielewska, K. M. 1999. Clinical and Experimental Pharmacology and Physiology 26(1):11-19.
23. Sheha, M., Al-Tayeb, A., EI-Sherief, H., and Farag, H. 2003. Bioorganic & Medicinal Chemistry 11(8):1865-1872.
24. Simpkins, J. W., Bahimy, M. H., and Bodor, N. 1991. Proc. Program Int. Symp. Controlled Release Bioact. Mater. 18:199-200.
25. Suglyama, Y., and Suzuki, H. 1987. Pharm Tech Japan 3(5):419-422.
26. Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., and Kopple, K. D. 2002. J. Med. Chem. 45:2615-2623.
27. Whei-Mei, W., Pop, E., Shek, E., and Bodor N. 1989. J. Med. Chem. 32:1782-1788.
28. Wimwood, D. 1989. Chemtracts: Organic Chemistry 2(4):239-242.
29. Woodard, P. A. 1990. Drug Design and Delivery 6(1):15-28.
30. Xia, X., and Xie, Z. 2001. Bioinformatics 17:569-570.